Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6986 results

Sort By:

Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer

Study ID: NCT04812912
Start Date: 2021-03-18
End Date: 2026-03-18
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Hormone biomarker analysis

QoL Questionnaires

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

Study ID: NCT06179888
Start Date: 2024-08-27
End Date: 2027-10-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

78

Intervention / Treatment

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Computed Tomography

Iberdomide

Magnetic Resonance Imaging

Patient Monitoring

Positron Emission Tomography

Skeletal Survey X-Ray

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

Study ID: NCT06657222
Start Date: 2024-12-13
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

130

Intervention / Treatment

TUB-030

Sponsor

Tubulis GmbH

Source: clinicaltrials.gov

Share:
Add to list

A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma

Study ID: NCT05607095
Start Date: 2022-11-01
End Date: 2026-05-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

Lifileucel (LN-144/LN-145)

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Using Xe MRI to Guide Radiation Therapy for Lung Cancer

Study ID: NCT06925295
Start Date: 2025-08
End Date: 2027-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

15

Intervention / Treatment

Xenon MRI

Pulmonary Function Testing

Quality of Life Questionnaire

Medical Research Council Dyspnea score

St. George's Respiratory Questionnaire

Blood Biomarkers

Sponsor

Sean Fain

Source: clinicaltrials.gov

Share:
Add to list

Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers

Study ID: NCT04712877
Start Date: 2022-06-15
End Date: 2026-06-15
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

ctDNA, tumor NGS

Sponsor

Lung Cancer Mutation Consortium

Source: clinicaltrials.gov

Share:
Add to list

Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome

Study ID: NCT04792463
Start Date: 2015-03-03
End Date: 2026-07-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment
Sponsor

Mohamed Abdel-Rahman

Source: clinicaltrials.gov

Share:
Add to list

Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors

Study ID: NCT06651593
Start Date: 2025-07-02
End Date: 2030-09-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

SAR444881

Cemiplimab

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass

Study ID: NCT06566716
Start Date: 2024-09-06
End Date: 2026-08
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

CleoDX ovarian cancer test

Sponsor

Cleo Diagnostics Ltd

Source: clinicaltrials.gov

Share:
Add to list

BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer

Study ID: NCT06756932
Start Date: 2025-02-04
End Date: 2027-07-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

120

Intervention / Treatment

BGB-21447

Fulvestrant

BGB-43395

Sponsor

BeOne Medicines

Source: clinicaltrials.gov

Share:
Add to list